2026 Heinz Wiendl: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	105	599	553	36	35	652	35710
Medicine	105	6822	6415	391	375	724	36425

Overview

Heinz Wiendl is affiliated with the University of Münster in Germany and specializes in medical research with a focus on neurology. Their work extensively covers multiple sclerosis and related neurological disorders, contributing to the fields of neurology, pathology, immunology, oncology, and molecular biology.

The scientist's research predominantly addresses multiple sclerosis, peripheral neuropathies, neuroinflammation, autoimmune neurological disorders, and chronic lymphocytic leukemia. Key topics investigated include:

Multiple Sclerosis Research Studies
Peripheral Neuropathies and Disorders
Polyomavirus and related diseases
Neuroinflammation and Neurodegeneration Mechanisms
Myasthenia Gravis and Thymoma
Autoimmune Neurological Disorders and Treatments
Chronic Lymphocytic Leukemia Research

Heinz Wiendl has published numerous papers in respected journals, with recent works notably appearing in venues such as the New England Journal of Medicine, Brain, Nature Communications, JAMA Neurology, and The Lancet Neurology. Selected recent publications include:

Ofatumumab versus Teriflunomide in Multiple Sclerosis (2020), New England Journal of Medicine
How patients with multiple sclerosis acquire disability (2022), Brain
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis (2020), Nature Communications
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis (2023), JAMA Neurology
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023), The Lancet Neurology

The scientist frequently collaborates with a group of researchers including:

Sven G. Meuth
Catharina C. Groß
Luisa Klotz
Andreas Schulte-Mecklenbeck
Gerd Meyer zu Hörste

Heinz Wiendl's publications are often featured in specialized journals such as:

Neurology
Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Journal
Multiple Sclerosis and Related Disorders
Therapeutic Advances in Neurological Disorders

Their scholarly production spans over 700 publications mainly in medicine, with a significant emphasis on neurological sciences and immunology, reflecting a broad and interdisciplinary research portfolio.

Best Publications

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

1085
Citations
Ofatumumab versus Teriflunomide in Multiple Sclerosis

Stephen L. Hauser;Amit Bar-Or;Jeffrey A. Cohen;Giancarlo Comi

651
Citations
Expression of the B7-Related Molecule B7-H1 by Glioma Cells: A Potential Mechanism of Immune Paralysis

Sabine Wintterle;Bettina Schreiner;Meike Mitsdoerffer;Dagmar Schneider

501
Citations
Leitlinien für Diagnostik und Therapie in der Neurologie

H. C. Diener;C. Weimar;P. Berlit;G. Deuschl

485
Citations
Acute disseminated encephalomyelitis: an update.

Til Menge;Bernhard Hemmer;Stefan Nessler;Heinz Wiendl

483
Citations
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.

Christian Blank;Juergen Kuball;Simon Voelkl;Heinz Wiendl

444
Citations
A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape.

Heinz Wiendl;Meike Mitsdoerffer;Valeska Hofmeister;Jörg Wischhusen

428
Citations
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

David Schafflick;Chenling A. Xu;Maike Hartlehnert;Michael Cole

419
Citations
Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis.

Christian G. Bien;Jan Bauer;Thomas L. Deckwerth;Heinz Wiendl

417
Citations
Early detrimental T-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation

Christoph Kleinschnitz;Nicholas Schwab;Peter Kraft;Ina Hagedorn

408
Citations
Teriflunomide and Its Mechanism of Action in Multiple Sclerosis

Amit Bar-Or;Andrew Pachner;Francoise Menguy-Vacheron;Johanne Kaplan

402
Citations
Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature

Christoph Kleinschnitz;Peter Kraft;Angela Dreykluft;Ina Hagedorn

401
Citations
Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis

Bettina Schreiner;Meike Mitsdoerffer;Bernd C. Kieseier;Lieping Chen

388
Citations
Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells.

Oliver Neuhaus;Cinthia Farina;Alexander Yassouridis;Heinz Wiendl

381
Citations
Clinical relevance of brain volume measures in multiple sclerosis.

Nicola De Stefano;Laura Airas;Nikolaos Grigoriadis;Heinrich P. Mattle

368
Citations
The role of regulatory T cells in multiple sclerosis

Alla L Zozulya;Heinz Wiendl

321
Citations
Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society.

Nico Melzer;Tobias Ruck;Peter Fuhr;Ralf Gold

317
Citations
A PD-1 polymorphism is associated with disease progression in multiple sclerosis.

Antje Kroner;Matthias Mehling;Bernhard Hemmer;Peter Rieckmann

311
Citations
Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

Heinz Wiendl;Reinhard Hohlfeld

310
Citations
Daclizumab HYP versus interferon beta-1a in relapsing multiple sclerosis

Ludwig Kappos;Heinz Wiendl;Krzysztof Selmaj;Douglas L. Arnold

299
Citations
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.

H. Wiendl;K. V. Toyka;P. Rieckmann;R. Gold

295
Citations

Frequent Co-Authors

Sven G. Meuth University of Münster

Luisa Klotz University Hospital Münster

Catharina C. Gross University of Münster

Bernd C. Kieseier Novartis (Switzerland)

Christoph Kleinschnitz University of Duisburg-Essen

Frauke Zipp Johannes Gutenberg University of Mainz

Ludwig Kappos University Hospital of Basel

Ralf Gold Ruhr University Bochum

Hans-Peter Hartung Heinrich Heine University Düsseldorf

Maria Trojano University of Bari Aldo Moro

External Links

Wikipedia of Heinz Wiendl Personal website of Heinz Wiendl

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Exploring Immunology often leads students to consider complementary healthcare careers. Many find that nursing provides a practical bridge to apply immunological concepts in clinical settings. For those interested in faster entry into nursing, programs like the easiest accelerated nursing programs offer streamlined paths to earning a Bachelor of Science in Nursing.

For individuals seeking foundational nursing roles without extensive upfront requirements, lpn programs with easiest admission requirements can be an accessible option. Licensed Practical Nurses play a vital role in patient care, including immunological monitoring and support.

Advancing nursing careers often involves becoming a Nurse Practitioner, specializing in areas like immunology or mental health. Those interested can explore flexible study options through easiest online nurse practitioner programs that balance quality education with manageable admissions.

Specialized fields such as Psychiatric Mental Health Nursing benefit from strong clinical experience. Programs known for their practical training, like the top pmhnp programs, enhance job readiness and career prospects in neuroimmunology-related care.